GlassScriptPhysician profile
Peter J Schuman
NPI 1447242532
$4,208.76
in general payments reported to CMS, 2019-2025
24 companies · $1,508 in 2025
The $1,508 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $262 · 2022: $353 · 2023: $978 · 2024: $1,108 · 2025: $1,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,233 · Travel and Lodging: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,233.10 |
| Travel and Lodging | $360.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $576.40 | 2023-2024 | Iovera, Zilretta, Exparel |
| Spr Therapeutics, INC | $518.18 | 2023-2025 | Sprint Pns System |
| Novo Nordisk INC | $486.48 | 2023-2025 | Wegovy |
| Abbvie INC. | $305.33 | 2023-2025 | |
| Intuitive Surgical, INC. | $291.25 | 2022 | |
| Saluda Medical Americas, INC. | $258.91 | 2025 | Evoke |
| Boston Scientific Corporation | $235.49 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept |
| Lilly USA, LLC | $207.53 | 2024-2025 | Emgality |
| Nalu Medical, INC. | $184.15 | 2025 | Nalu Neurostimulation System |
| Si-Bone, INC. | $160.10 | 2025 | |
| Merz North America, INC. | $148.59 | 2025 | |
| Penumbra, INC. | $135.92 | 2021 | |
| Biogen, INC. | $126.23 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $124.15 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $122.88 | 2024 | Keytruda |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $68.95 | 2024-2025 | Orthovisc, Monovisc |
| United Imaging Healthcare North America LLC | $61.29 | 2022 | |
| Ibsa Pharma INC. | $44.50 | 2023-2024 | Tirosint, Licart, Flector |
| Bioventus LLC | $36.55 | 2025 | Xcell, Supartz Fx Sodium Hyaluronate |
| International Rehabilitative Sciences, INC | $34.25 | 2023 | Rs 4i Plus Sequential Stimulator |
| Scilex Pharmaceuticals INC. | $26.45 | 2024 | |
| Neurocrine Biosciences, INC. | $22.87 | 2024 | Ingrezza |
| Pfizer INC. | $16.59 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $15.72 | 2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Schuman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.